Once TLR2 signalling is initiated during BE and early-stage adenocarcinoma, the positive amplification of TLR2-mediated inflammation and TLR2 expression on macrophages contributes to their polarisation and activation during disease progression. The gene discussed is TLR2; the disease is Barrett esophagus.